Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 5/2014

01.10.2014 | Case Report

Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule

verfasst von: Yoshihito Kano, Sei Kakinuma, Fumio Goto, Seishin Azuma, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Mina Nakagawa, Atsushi Kudo, Minoru Tanabe, Susumu Kirimura, Tomonori Amano, Takashi Ito, Takumi Akashi, Yasuhiro Asahina, Mamoru Watanabe

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Primary neuroendocrine carcinomas (NECs) in the liver are very rare; however, several reports have described cases of a primary hepatic NEC combined with a hepatocellular carcinoma (HCC). We present the first report of a primary hepatic NEC with a cholangiocellular carcinoma (CCC) component in one nodule in a patient with a metachronous liver HCC. A 73-year old man who had received partial hepatectomy surgery because of a primary HCC and a primary CCC two years prior was diagnosed with a primary hepatic NEC after surgical treatment. Histological analysis of the resected tumor revealed that the tumor consisted of a predominant NEC area with a partial CCC component in one nodule and that the NEC cells were negative for markers of pancreatic NEC. Neoplastic cells in both the NEC and CCC component focally expressed CD44, a representative marker for cancer-initiating cells, and the CD44-positive cells in the NEC component were seen in the vicinity of those in the CCC component of one nodule. This case report provides suggestive information for the origin of primary hepatic NECs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int. 2001;51:874–8.PubMedCrossRef Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int. 2001;51:874–8.PubMedCrossRef
2.
Zurück zum Zitat Yang CS, Wen MC, Jan YJ, et al. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc. 2009;72(8):430–3.PubMedCrossRef Yang CS, Wen MC, Jan YJ, et al. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc. 2009;72(8):430–3.PubMedCrossRef
3.
Zurück zum Zitat Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 2003;33:214–8.PubMedCrossRef Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 2003;33:214–8.PubMedCrossRef
4.
Zurück zum Zitat Yamaguchi R, Nakashima O, Ogata T, et al. Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int. 2004;54:861–5.PubMedCrossRef Yamaguchi R, Nakashima O, Ogata T, et al. Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int. 2004;54:861–5.PubMedCrossRef
5.
Zurück zum Zitat Nobuaki K, Katsumi A, Hirohiko S, et al. Neuroendocrine carcinoma of the liver coexisting with the intrahepatic cholangiocarcinoma. Jpn J Gastroenterol Surg. 2012;45(10):1012–9.CrossRef Nobuaki K, Katsumi A, Hirohiko S, et al. Neuroendocrine carcinoma of the liver coexisting with the intrahepatic cholangiocarcinoma. Jpn J Gastroenterol Surg. 2012;45(10):1012–9.CrossRef
6.
Zurück zum Zitat Fidler JL, Fletcher JG, Reading CC, et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol. 2003;181(3):775–80.PubMedCrossRef Fidler JL, Fletcher JG, Reading CC, et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol. 2003;181(3):775–80.PubMedCrossRef
7.
Zurück zum Zitat Kawasato R, Shiratsuki S, Iwamoto T, et al. A case of primary hepatic neuroendocrine carcinoma clinically suggested. Yamaguchiigaku. 2014;63:53–60.CrossRef Kawasato R, Shiratsuki S, Iwamoto T, et al. A case of primary hepatic neuroendocrine carcinoma clinically suggested. Yamaguchiigaku. 2014;63:53–60.CrossRef
8.
Zurück zum Zitat Fragulidis GP, Chondrogiannis K, Vezakis A, et al. Neuroendocrine differentiation in embryonal type hepatoblastoma. Hepatol Res. 2013;43(3):320–6.PubMedCrossRef Fragulidis GP, Chondrogiannis K, Vezakis A, et al. Neuroendocrine differentiation in embryonal type hepatoblastoma. Hepatol Res. 2013;43(3):320–6.PubMedCrossRef
9.
Zurück zum Zitat Vinik AI, Silva MP, Woltering EA, et al. Biochemical testing for neuroendocrine tumors. Pancreas. 2009;38(8):876–89.PubMedCrossRef Vinik AI, Silva MP, Woltering EA, et al. Biochemical testing for neuroendocrine tumors. Pancreas. 2009;38(8):876–89.PubMedCrossRef
10.
Zurück zum Zitat La Rosa S, Marando A, Sessa F, et al. Mixed adenoneuroendocrine carcinomas (manecs) of the gastrointestinal tract: an update. Cancers. 2012;4(1):11–30.PubMedCrossRefPubMedCentral La Rosa S, Marando A, Sessa F, et al. Mixed adenoneuroendocrine carcinomas (manecs) of the gastrointestinal tract: an update. Cancers. 2012;4(1):11–30.PubMedCrossRefPubMedCentral
11.
Zurück zum Zitat Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol. 1987;11:S71–86.CrossRef Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol. 1987;11:S71–86.CrossRef
12.
Zurück zum Zitat Solcia E, Klöppel G, Sobin L.H. Histological typing of endocrine tumours (WHO International Histological Classification of Tumours). 2nd ed. Berlin: Springer; 2000 Solcia E, Klöppel G, Sobin L.H. Histological typing of endocrine tumours (WHO International Histological Classification of Tumours). 2nd ed. Berlin: Springer; 2000
13.
Zurück zum Zitat Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 13–14 Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 13–14
14.
Zurück zum Zitat Yasuda E, Takeshita A, Murata S, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56(12):749–54.PubMedCrossRef Yasuda E, Takeshita A, Murata S, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56(12):749–54.PubMedCrossRef
16.
Zurück zum Zitat Tovuu LO, Imura S, Utsunomiya T, et al. Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma. Int J Clin Oncol. 2013;18:651–6.PubMedCrossRef Tovuu LO, Imura S, Utsunomiya T, et al. Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma. Int J Clin Oncol. 2013;18:651–6.PubMedCrossRef
17.
Zurück zum Zitat Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6(3):339–53.PubMedCrossRef Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6(3):339–53.PubMedCrossRef
18.
Zurück zum Zitat Kano Y, Tsuchiya K, Zheng X, et al. The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein. Biochem Biophys Res Commun. 2013;432(1):175–81.PubMedCrossRef Kano Y, Tsuchiya K, Zheng X, et al. The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein. Biochem Biophys Res Commun. 2013;432(1):175–81.PubMedCrossRef
19.
Zurück zum Zitat Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10:1171–5.PubMedCrossRef Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10:1171–5.PubMedCrossRef
20.
Zurück zum Zitat Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case. Surg Today. 2011;41:1655–60.PubMedCrossRef Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case. Surg Today. 2011;41:1655–60.PubMedCrossRef
21.
Zurück zum Zitat Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):514–23.PubMedCrossRef Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):514–23.PubMedCrossRef
22.
Zurück zum Zitat Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res. 2012;18:1830–6.PubMedCrossRef Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res. 2012;18:1830–6.PubMedCrossRef
23.
Zurück zum Zitat Kulke MH, Wu B, Ryan DP, et al. A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci. 2006;51(6):1033–8.PubMedCrossRef Kulke MH, Wu B, Ryan DP, et al. A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci. 2006;51(6):1033–8.PubMedCrossRef
Metadaten
Titel
Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule
verfasst von
Yoshihito Kano
Sei Kakinuma
Fumio Goto
Seishin Azuma
Yuki Nishimura-Sakurai
Yasuhiro Itsui
Mina Nakagawa
Atsushi Kudo
Minoru Tanabe
Susumu Kirimura
Tomonori Amano
Takashi Ito
Takumi Akashi
Yasuhiro Asahina
Mamoru Watanabe
Publikationsdatum
01.10.2014
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 5/2014
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-014-0521-3

Weitere Artikel der Ausgabe 5/2014

Clinical Journal of Gastroenterology 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.